ROZVIN AS 10/75

ROZVIN AS 10/75

Composition Rosuvastatin 10mg
Aspirin 75mg
Dosage CAPSULE
Packing Size 10×10
Packing Strip

Professional Care, Consistent Results

At Avecia Healthcare, we believe that professionalism forms the foundation of trust. Our expert team is committed to providing healthcare solutions that meet global standards.

Every product we deliver is a result of thorough research, precision manufacturing, and rigorous quality checks—ensuring consistency in performance and reliability.

With a patient-first approach and a strong ethical foundation, we aim to make a lasting difference in lives by offering care that is both dependable and professionally crafted.

Additional information

ROZVIN AS 10/75 — Rosuvastatin 10 mg + Aspirin 75 mg Tablets

Overview

ROZVIN AS 10/75 is a dual-action cardiovascular medication that combines Rosuvastatin 10 mg, a lipid-lowering statin, with Aspirin 75 mg, a low-dose antiplatelet agent. This combination is formulated to manage cholesterol levels while reducing the risk of blood clot formation, helping prevent heart attack, stroke, and other cardiovascular events in at-risk patients.

By targeting two major cardiovascular risk factors—high cholesterol and platelet aggregation, ROZVIN AS 10/75 provides comprehensive heart protection in a single convenient tablet.


Composition

Each tablet contains:

  • Rosuvastatin 10 mg – HMG-CoA reductase inhibitor that lowers LDL cholesterol, total cholesterol, and triglycerides while increasing HDL cholesterol.

  • Aspirin 75 mg – Antiplatelet agent that prevents platelet aggregation, reducing the risk of thrombotic cardiovascular events.

(Excipients q.s., as per approved formulation.)


Dosage Form

  • Tablet


Therapeutic Class

  • Lipid-Lowering & Antiplatelet Therapy / Cardiovascular Protection


Indications

ROZVIN AS 10/75 Tablets are indicated for:

  • Patients with hypercholesterolemia and high cardiovascular risk

  • Prevention of heart attack, stroke, or other thrombotic events

  • Secondary prevention in patients with previous myocardial infarction or coronary artery disease

  • Patients requiring cholesterol management combined with antiplatelet therapy


Mechanism of Action

  • Rosuvastatin inhibits the HMG-CoA reductase enzyme, reducing cholesterol synthesis in the liver and improving the lipid profile.

  • Aspirin irreversibly inhibits platelet aggregation, preventing thrombus formation and lowering the risk of cardiovascular events.

  • The combination addresses cholesterol management and blood clot prevention simultaneously, providing effective cardiovascular protection.


Dosage and Administration

  • Recommended Dose: As prescribed by the physician, usually once daily

  • Route: Oral

  • Duration: Long-term therapy as advised by a healthcare provider

Note: Regular monitoring of lipid profile, liver function, and bleeding risk is recommended during therapy.


Benefits

  • Lowers LDL cholesterol and triglycerides

  • Increases HDL cholesterol

  • Prevents platelet aggregation and blood clots

  • Reduces risk of heart attack, stroke, and atherosclerosis

  • Convenient once-daily tablet improves patient compliance


Side Effects

ROZVIN AS 10/75 is generally well tolerated. Possible side effects include:

  • Mild gastrointestinal disturbances (nausea, abdominal discomfort)

  • Headache or dizziness

  • Muscle pain or weakness (rare, associated with statins)

  • Increased risk of bleeding due to Aspirin

Patients should consult their physician if side effects persist or worsen.


Precautions

  • Avoid in patients with active bleeding disorders or history of hemorrhagic stroke

  • Use with caution in liver or kidney impairment

  • Not recommended during pregnancy or lactation

  • Inform your doctor about other medications to prevent interactions

  • Regular monitoring of liver enzymes, lipid profile, and bleeding risk is advised


Storage

Store below 25°C, in a dry place away from sunlight. Keep out of reach of children.


Key Product Information

  • Brand Name: ROZVIN AS 10/75

  • Composition: Rosuvastatin 10 mg + Aspirin 75 mg

  • Dosage Form: Tablet

  • Therapeutic Class: Lipid-Lowering & Antiplatelet / Cardiovascular Protection

  • Manufacturer: [Insert Company Name]

  • Packaging: [Example: 10×10 Tablets / Strip]


Why Choose ROZVIN AS 10/75

  • Combines cholesterol management and antiplatelet therapy in a single tablet

  • Helps reduce cardiovascular risk in high-risk patients

  • Convenient once-daily dosing improves compliance

  • Manufactured under strict GMP-certified quality standards


Conclusion

ROZVIN AS 10/75 (Rosuvastatin 10 mg + Aspirin 75 mg Tablets) provides dual cardiovascular protection by managing cholesterol levels and preventing blood clots. This comprehensive therapy reduces the risk of heart attack, stroke, and atherosclerosis, supporting long-term heart health and overall cardiovascular wellness.